Cytogenix (fka CYGX)

[neo43]

peace, those running CYGX have a choice, IMHO:

1. they can obtain substantial financing at the current share price, and thus reassure current investors; OR

2. they can scrape by for another 4 to 6 months (maybe less) with minimal financing in the hope/expectation that technological and/or other developments in the pipeline are likely to increase the SP substantially during that period, thereby allowing financing with much less dilution.

I believe they're choosing the 2nd option, because they're focusing on the LONG-TERM best interests of the company and its shareholders.